A systematic search was conducted across multiple platforms including:
National Center for Biotechnology Information repositories (Sources )
Kyowa Kirin and Creative Biolabs technical resources (Sources )
No matches were found for "DOF4.5 Antibody" in:
Antibody nomenclature databases
Structural biology studies
Commercial product listings
Several antibodies with alphanumeric designations were identified but none correlate to "DOF4.5":
| Antibody Designation | Target/Function | Source |
|---|---|---|
| RM4-5 | Mouse CD4 antigen | |
| 1E12 | PF4/heparin complexes | |
| C#5/C#21 | DR4/DR5 receptors | |
| MAB5580 | Mouse F4/80 antigen |
Nomenclature Issues:
Development Stage:
Preclinical candidates often lack public documentation
Discontinued projects may have limited publication history
Proprietary Restrictions:
Industry-developed antibodies may be under patent protection
Academic collaborations sometimes delay publication
Confirm exact spelling/nomenclature with original source
Check regional patent databases (USPTO, EPO, JPO)
Contact antibody development consortia:
The Antibody Society
International Immunogenetics Information System
Given the lack of specific information on "DOF4.5 Antibody" in the search results, I will create a general FAQ for researchers on antibodies, focusing on aspects relevant to academic research scenarios. This will include experimental design, data analysis, and methodological considerations.
To evaluate the specificity and sensitivity of an antibody, follow these steps:
Specificity: Use Western blotting or immunohistochemistry to test the antibody against known positive and negative controls. Ensure that the antibody binds specifically to the target protein without cross-reacting with other proteins.
Sensitivity: Determine the minimum concentration of the target protein that the antibody can detect. This can be done by serial dilution of the target protein in a Western blot or ELISA assay.
Controls: Include both positive and negative controls in each experiment to validate the results.
Several techniques are used to validate antibodies:
Western Blotting: To check for specificity and sensitivity.
Immunohistochemistry (IHC): To assess the antibody's ability to bind to the target protein in tissue samples.
ELISA: To quantify the antibody's binding affinity.
Flow Cytometry: For cell surface protein detection.
Immunoprecipitation (IP): To confirm the antibody's ability to pull down the target protein.
When encountering contradictory data:
Re-evaluate Experimental Conditions: Check for differences in sample preparation, antibody concentration, and incubation times.
Use Multiple Detection Methods: Validate findings using different techniques (e.g., Western blot and IHC).
Statistical Analysis: Apply appropriate statistical tests to determine if observed differences are significant.
Literature Review: Compare your results with published studies to identify potential explanations for discrepancies.
To map the epitope recognized by an antibody:
Peptide Arrays: Use peptide arrays to identify the specific sequence recognized by the antibody.
Mutagenesis Studies: Create point mutations in the target protein and assess the effect on antibody binding.
Structural Biology Techniques: Use X-ray crystallography or cryo-EM to visualize the antibody-antigen complex.
When producing antibodies:
Immunogen Selection: Choose an immunogen that is representative of the target protein's native structure.
Host Selection: Select an appropriate host for immunization (e.g., mice, rabbits).
Screening Techniques: Use ELISA or Western blotting to screen hybridoma supernatants for specific antibody production.
Purification Methods: Use affinity purification (e.g., protein A or G) to isolate the antibody.
To maintain antibody stability:
Storage Conditions: Store antibodies at -20°C or -80°C in a buffer that maintains their stability (e.g., PBS with glycerol).
Avoid Freeze-Thaw Cycles: Minimize freeze-thaw cycles to prevent degradation.
Concentration and Buffer: Use the recommended concentration and buffer to prevent aggregation or denaturation.
Common issues include:
Non-specific Binding: Use blocking agents or optimize antibody concentration.
Low Signal: Increase antibody concentration or use a more sensitive detection method.
Background Noise: Optimize washing steps or use a different secondary antibody.